Pain managementMay 14, 2025

Long-term nerve pain after COVID-19 infection: a review and future research ideas

Updated Dec 27, 2025

Abstract

Approximately 10% of people with SARS-CoV-2 may develop chronic neuropathic pain.

Neuropathic pain can occur during acute, post-acute, and long-COVID phases of SARS-CoV-2 infection.
Factors such as disease severity, higher body mass index, prior psychological conditions, and addiction history may be linked to post-acute SARS-CoV-2 neuropathic symptoms.
Sex differences could affect the prevalence of these symptoms.
PASC symptoms may complicate pain perception due to their multisystem nature, including mood disorders and cognitive dysfunction.
Potential underlying mechanisms include immune system changes, ongoing effects of viral proteins, and alterations in brain structure.
Management of neuropathic pain generally involves various treatment strategies.

Simplified

PURPOSE OF REVIEW: Neuropathic pain is a recognized and debilitating symptom of SARS-CoV-2 infection across acute, post-acute, and long-COVID phases. Initially emerging as acute or subacute symptoms, these neuropathic manifestations can evolve into chronic conditions, with approximately 10% of all SARS-CoV-2 cases (estimated 65 million individuals globally) developing post-acute SARS-CoV-2 (PASC) neuropathic sequalae. Given the limited literature specifically addressing neuropathic pain related to PASC, a deeper understanding is needed to improve management and reduce patient burden.

RECENT FINDINGS: PASC symptoms are associated with disease severity, elevated body mass indexes, preexisting psychological conditions, and addiction history. Sex differences appear to influence prevalence, and the multisystem nature of PASC complicates symptom presentation, with mood disorders, fatigue, and cognitive dysfunction contributing to altered pain perception. Proposed mechanisms include immune dysregulation, persistent viral protein effects, and neuroanatomical changes. Management typically involves a multimodal approach.

SUMMARY: This review examines SARS-CoV-2 neuropathic pain across the illness trajectory, examining its pathophysiology, prevalence, and treatment. It highlights the potential for subacute neuropathic symptoms to become chronic and calls for future research to refine long-term management strategies and assess broader healthcare implications.

Full Text

Full text is available at the source.

View Full Text ↗

Funding

Competing interests

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

PubMed

Abstract

Full Text

Funding

Competing interests

Related papers

What Lands in Your Inbox Each Week: